Colorectal Cancer Clinical Trials in Massachusetts

Showing 221-227 of 227 trials

Improving Followup of Abnormal Colon Cancer Screening Tests

NCT00436137

The purpose of this study is to determine whether direct mailings to patients with positive fecal occult blood tests can increase rates of performing followup colonoscopy.

Colorectal Cancer

Harvard Vanguard Medical Associates70 participantsStarted Jun 2007

Newton, Massachusetts, United States

COMPLETEDPhase 222 miles

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

NCT00003254

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Ethynyluracil may help fluorouracil kill more cancer cells by making tumor cells more sensitive to the drug. PURPOSE: Phase II trial to study the effectiveness of fluorouracil plus ethynyluracil in treating patients with advanced colorectal cancer that has not responded to fluorouracil.

Colorectal Cancer

SWOG Cancer Research Network75 participantsStarted Apr 1998

Mobile, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +83 more locations

Improving Followup of Abnormal Colon Cancer Screening Tests

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Colorectal Cancer Trials in Other Cities

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.

Other Conditions in Massachusetts